Page last updated: 2024-09-05

lu 135252 and Cerebrovascular Disorders

lu 135252 has been researched along with Cerebrovascular Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amann, K; Esslinger, JP; Orth, SR; Raschack, M; Ritz, E; Schwarz, U	1

Other Studies

1 other study(ies) available for lu 135252 and Cerebrovascular Disorders

Article	Year
Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:4 Topics: Animals; Blood Pressure; Body Weight; Cerebrovascular Disorders; Endothelin Receptor Antagonists; Endothelin-1; Kidney; Male; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Sodium, Dietary	1998

Article

Year

Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats.

Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:4

Topics: Animals; Blood Pressure; Body Weight; Cerebrovascular Disorders; Endothelin Receptor Antagonists; Endothelin-1; Kidney; Male; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Sodium, Dietary

1998